US equities
|
MU
$1,082.12
▲+3.50%
NVDA
$236.73
▼-1.05%
SNDK
$1,709.52
▲+2.95%
SPCX
$166.78
▼-2.99%
AMD
$643.41
▼-0.93%
TSLA
$377.15
▼-0.93%
INTC
$112.49
▼-0.01%
AAPL
$337.28
▲+1.09%
MU
$1,082.12
▲+3.50%
NVDA
$236.73
▼-1.05%
SNDK
$1,709.52
▲+2.95%
SPCX
$166.78
▼-2.99%
AMD
$643.41
▼-0.93%
TSLA
$377.15
▼-0.93%
INTC
$112.49
▼-0.01%
AAPL
$337.28
▲+1.09%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Michael Klichinsky
Recent news which mentions Michael Klichinsky
Lab Notes: Arbutus and Penn make headway on Covid-19 treatments; Carisma partners with Merck
December 10, 2021
Tickers
INNO
Tags
Arbutus Biopharma Corporation
Virpax Pharmaceuticals Inc/
Michael Klichinsky
From
Business Journals
Lab notes: Incyte gets two FDA approvals, Coriell gets $12.4M research grant, and more
September 24, 2021
Tickers
INNO
Tags
Michael Klichinsky
Ravi K/ Amaravadi
Anthony P/ Mack
From
Business Journals